UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Methadone and naltrexone in heroin addiction--an explanation from the SBU

Läkartidningen, 2002-02, Vol.99 (6), p.552

2002

Link zum Volltext

Verfügbarkeit prüfen

Documented effect of methadone, but not naltrexone

Läkartidningen, 2002-02, Vol.99 (6), p.551

Heilig, Markus

2002

Link zum Volltext

Verfügbarkeit prüfen

Subutex is the first link in the care continuity of opiate dependence

Läkartidningen, 2003-04, Vol.100 (15), p.1367

Arnsvik, Anders

2003

Link zum Volltext

Verfügbarkeit prüfen

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

American Journal of Psychiatry, 2018-12, Vol.175 (12), p.1205-1215

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

The Lancet (British edition), 2018-01, Vol.391 (10118), p.309-318

2018

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial

JAMA psychiatry (Chicago, Ill.), 2017-12, Vol.74 (12), p.1197

2017

Link zum Volltext

Verfügbarkeit prüfen

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial

JAMA internal medicine, 2018-06, Vol.178 (6), p.764

2018

Link zum Volltext

Verfügbarkeit prüfen

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

The New England journal of medicine, 2016-03, Vol.374 (13), p.1232-1242

2016

Link zum Volltext

Verfügbarkeit prüfen

Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial

The American journal of psychiatry, 2016-05, Vol.173 (5), p.491-498

2016

Link zum Volltext

Verfügbarkeit prüfen

Management of Opioid Analgesic Overdose

The New England journal of medicine, 2012-07, Vol.367 (2), p.146-155

Boyer, Edward W

2012

Link zum Volltext

Verfügbarkeit prüfen

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

The Lancet (British edition), 2011, Vol.377 (9776), p.1506-1513

2011

Link zum Volltext

Verfügbarkeit prüfen

Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain

The New England journal of medicine, 2014-06, Vol.370 (25), p.2387-2396

2014

Link zum Volltext

Verfügbarkeit prüfen

Addressing the Fentanyl Threat to Public Health

The New England journal of medicine, 2017-02, Vol.376 (7), p.605-607

2017

Link zum Volltext

Verfügbarkeit prüfen

Extended‐release injectable naltrexone for opioid use disorder: a systematic review

Addiction (Abingdon, England), 2018-07, Vol.113 (7), p.1188-1209

2018

Link zum Volltext

Verfügbarkeit prüfen

Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres

Journal of controlled release, 2017-06, Vol.255, p.27-35

2017

Link zum Volltext

Verfügbarkeit prüfen

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

Drug and alcohol dependence, 2019-07, Vol.200, p.34-39

2019

Link zum Volltext

Verfügbarkeit prüfen

Buprenorphine for managing opioid withdrawal

Cochrane database of systematic reviews, 2017-02, Vol.2 (2), p.CD002025

2017

Link zum Volltext

Verfügbarkeit prüfen

New directions in the treatment of opioid withdrawal

The Lancet (British edition), 2020-06, Vol.395 (10241), p.1938-1948

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults

The journal of clinical psychiatry, 2014-08, Vol.75 (8), p.e785

2014

Link zum Volltext

Verfügbarkeit prüfen

Managing Opioid Withdrawal in the Emergency Department With Buprenorphine

Annals of emergency medicine, 2019-05, Vol.73 (5), p.481-487

2019

Link zum Volltext

Verfügbarkeit prüfen

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

Obesity (Silver Spring, Md.), 2011-01, Vol.19 (1), p.110-120

2011

Link zum Volltext

Verfügbarkeit prüfen

Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents

Proceedings of the National Academy of Sciences - PNAS, 2020-02, Vol.117 (5), p.2656-2662

2020

Link zum Volltext

Verfügbarkeit prüfen

The Next Stage of Buprenorphine Care for Opioid Use Disorder

Annals of internal medicine, 2018-11, Vol.169 (9), p.628

2018

Link zum Volltext

Verfügbarkeit prüfen

Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation

JAMA : the journal of the American Medical Association, 2022-03, Vol.327 (9), p.846

2022

Link zum Volltext

Verfügbarkeit prüfen

The Rising Price of Naloxone — Risks to Efforts to Stem Overdose Deaths

The New England journal of medicine, 2016-12, Vol.375 (23), p.2213-2215

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.604

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.294)
Mit Volltextzugriff
(3.629)

Publikationsform

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.867)
Life Sciences & Biomedicine
(3.807)
Male
(3.136)
Humans
(2.425)
Narcotic Antagonists - Administration & Dosage
(2.391)
Animals
(2.357)
Female
(1.652)
Narcotic Antagonists - Pharmacology
(1.500)
Biological And Medical Sciences
(1.494)
Pharmacology & Pharmacy
(1.405)
Rats
(1.381)
Medical Sciences
(1.221)
Dose-Response Relationship, Drug
(1.195)
Adult
(1.193)
Neurosciences & Neurology
(1.137)
Neurosciences
(1.091)
Naloxone - Administration & Dosage
(1.056)
Narcotic Antagonists - Therapeutic Use
(975)
Naltrexone - Administration & Dosage
(933)
Naloxone - Pharmacology
(773)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Psychopharmacology
(165)
European Journal Of Pharmacology
(140)
The Journal Of Pharmacology And Experimental Therapeutics
(112)
Psychopharmacologia
(111)
Brain Research
(104)
Drug And Alcohol Dependence
(101)
Pharmacology, Biochemistry And Behavior
(97)
Neuropsychopharmacology
(77)
Life Sciences
(64)
Addiction
(62)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Methadone and naltrexone in heroin addiction--an explanation from the SBU

Documented effect of methadone, but not naltrexone

Subutex is the first link in the care continuity of opiate dependence

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial

Management of Opioid Analgesic Overdose

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain

Addressing the Fentanyl Threat to Public Health

Extended‐release injectable naltrexone for opioid use disorder: a systematic review

Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

Buprenorphine for managing opioid withdrawal

New directions in the treatment of opioid withdrawal

Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults

Managing Opioid Withdrawal in the Emergency Department With Buprenorphine

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents

The Next Stage of Buprenorphine Care for Opioid Use Disorder

Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation

The Rising Price of Naloxone — Risks to Efforts to Stem Overdose Deaths

Suchergebnisse filtern